Helmut Robert Macke

Title: Helmut Robert Macke: Innovator in Peptide Compounds

Introduction

Helmut Robert Macke is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of peptide compounds, particularly in relation to somatostatin receptors. His innovative work has implications for both diagnostic methods and therapeutic treatments.

Latest Patents

Macke holds a patent for peptide compounds that exhibit improved binding affinity to somatostatin receptors. This invention involves a peptide compound that includes a somatostatin analogue and a chelating group linked to the N-terminal free amino group of the peptide. The somatostatin analogue features either an 1-naphthylalanine or a 3-benzothienylalanine residue in its 3-position. Additionally, the patent covers the use of this peptide compound labeled with a detectable element or therapeutic radionuclide, which can be utilized in diagnostic methods and therapeutic treatments for tumors.

Career Highlights

Macke is associated with Biosynthema Inc., where he continues to advance research in peptide technology. His work has garnered attention for its potential applications in medical science, particularly in oncology.

Collaborations

Macke has collaborated with esteemed colleagues such as Jean-Claude Reubi and Jörg Schmitt. These partnerships have contributed to the development and refinement of his innovative peptide compounds.

Conclusion

Helmut Robert Macke's contributions to the field of peptide compounds demonstrate his commitment to advancing medical science. His patented innovations hold promise for improving diagnostic and therapeutic approaches in treating tumors.